Relation

Relation Therapeutics is a London-based TechBio company founded in 2019. The company specializes in AI-driven drug discovery, focusing on complex diseases such as osteoporosis, neurodegeneration, and metabolic disorders. Led by Dame Emma Walmsley, Relation Therapeutics emphasizes interdisciplinary collaboration and has raised a total of $61.3 million in funding. The company combines machine learning, human genetics, and immune system research to explore relationships between genes, proteins, and drugs. Its methodology includes integrating active learning into drug discovery workflows and generating proprietary datasets through rapid lab experiments. This approach aims to identify biological targets and drug candidates for polygenic diseases that traditional methods may overlook. While specific drug candidates are not publicly disclosed, the pipeline likely includes small-molecule therapeutics or biologics derived from its AI platform insights.